Title of article :
Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results
Author/Authors :
Alfredo Rodriguez، نويسنده , , Victor Bernardi، نويسنده , , Jose Navia، نويسنده , , Julio Baldi، نويسنده , , Liliana Grinfeld، نويسنده , , Jorge Martinez، نويسنده , , Daniel Vogel، نويسنده , , Roberto Grinfeld، نويسنده , , Alejandro Delacasa، نويسنده , , Marcelo Garrido، نويسنده , , Raul Oliveri، نويسنده , , Eduardo Mele، نويسنده , , Igor Palacios، نويسنده , , William O’Neill، نويسنده , , Igor F. Palacios and the ERACI II Investigators، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2001
Pages :
8
From page :
51
To page :
58
Abstract :
BJECTIVES The purpose of this study was to compare percutaneous transluminal coronary revascularization (PTCR) employing stent implantation to conventional coronary artery bypass graft surgery (CABG) in symptomatic patients with multivessel coronary artery disease. BACKGROUND Previous randomized studies comparing balloon angioplasty versus CABG have demonstrated equivalent safety results. However, CABG was associated with significantly fewer repeat revascularization procedures. METHODS A total of 2759 patients with coronary artery disease were screened at seven clinical sites, and 450 patients were randomly assigned to undergo either PTCR (225 patients) or CABG (225 patients). Only patients with multivessel disease and indication for revascularization were enrolled. RESULTS Both groups had similar clinical demographics: unstable angina in 92%; 38% were older than 65 years, and 23% had a history of peripheral vascular disease. During the first 30 days, PTCR patients had lower major adverse events (death, myocardial infarction, repeat revascularization procedures and stroke) compared with CABG patients (3.6% vs. 12.3%, P = 0.002). Death occurred in 0.9% of PTCR patients versus 5.7% in CABG patients, p < 0.013, and Q myocardial infarction (MI) occurred in 0.9% PTCR versus 5.7% of CABG patients, p < 0.013. At follow-up (mean 18.5 ± 6.4 months), survival was 96.9% in PTCR versus 92.5% in CABG, p < 0.017. Freedom from MI was also better in PTCR compared to CABG patients (97.7% vs. 93.4%, p < 0.017). Requirements for new revascularization procedures were higher in PTCR than in CABG patients (16.8% vs. 4.8%, p < 0.002). CONCLUSIONS In this selected high-risk group of patients with multivessel disease, PTCR with stent implantation showed better survival and freedom from MI than did conventional surgery. Repeat revascularization procedures were higher in the PTCR group.
Keywords :
BARI , CABG , ERACI , Acute myocardial infarction , percutaneous transluminal coronary revascularization , Argentine Randomized Study: Coronary Angioplasty vs. Coronary Bypass Surgery in Multivessel Disease , PTCA , ERACI II , Argentine Randomized Study: Coronary Angioplasty with Stenting vs. Coronary Bypass Surgery in Multivessel Disease , mace , major adverse cardiac events , Bypass Angioplasty Revascularization Investigation , GABI , German Angioplasty Bypass Investigation , Coronary Artery Bypass Graft Surgery , AMI , PTCR , percutaneous transluminal coronary angioplasty
Journal title :
JACC (Journal of the American College of Cardiology)
Serial Year :
2001
Journal title :
JACC (Journal of the American College of Cardiology)
Record number :
596306
Link To Document :
بازگشت